Ultrasound technology, traditionally used for imaging, is rapidly evolving into a promising non-invasive therapy for brain disorders, according to researchers from Stanford University, the University of Plymouth, and Attune Neurosciences, as discussed in a recent article published in PLOS Biology. This innovative approach, known as transcranial ultrasound stimulation (TUS), aims to target specific areas of the brain, potentially aiding in the treatment of various conditions such as pain, alcoholism, obsessive-compulsive disorder (OCD), and Parkinson’s disease, all without the need for drugs or surgical interventions.
The researchers highlight that TUS can also function as a “search and rescue tool for the brain,” allowing clinicians to identify the sources of neurological issues before proceeding with treatment, paving the way for more personalized therapies. Despite the exciting potential, challenges remain, including the variability of individual brains and skulls, which necessitates further refinement of the technique to ensure widespread applicability.
Current advancements have led to the development of a portable TUS device that can be used safely at home after clinical assessments, reducing the need for frequent hospital visits—a significant benefit for those facing financial or logistical barriers to healthcare. Dr. Keith Murphy of Stanford emphasizes that making advanced brain therapies accessible to everyone is crucial, and the team’s progress is a step in that direction. Additionally, TUS can be integrated with emerging technologies to enhance communication between the brain and external devices, further broadening its therapeutic potential. Professor Elsa Fouragnan notes that while the understanding of brain conditions has improved, treatment advancements have not kept pace, making TUS a vital innovation in addressing these gaps and potentially benefiting millions worldwide.
Read More
